.png){kind=logo}
Technological process, which consists of mixing or inclusion of the therapeutic substance with an excipient or their mixtures,
Pharmaceutics Pharmacist Competitive Exams
Q. Technological process, which consists of mixing or inclusion of the therapeutic substance with an excipient or their mixtures,
Ans → embedding
Explanation →
This question is taken from the test/quiz post: one liners Pharmaceutics| B.Pharmacy| Pharmacy file-4 - attemp/practice
More oneliners in - one liners Pharmaceutics| B.Pharmacy| Pharmacy file-4
Q. The process of separating the lighter particles of a powder from the heavier ones by means of an up- ward-directed stream of fluid (gas or liquid).
Ans → elutriation
Explanation →
Q. Technological process, which consists of mixing or inclusion of the therapeutic substance with an excipient or their mixtures,
Ans → embedding
Explanation →
Q. Process of enclosing a drug in a (micro or nano) particle (capsule, liposome, polymer).
Ans → encapsulation
Explanation →
Q. Non-fluid colloidal network or polymer network that is expanded throughout its whole volume by a fluid.
Ans → gel
Explanation →
Q. Solutions (aqueous or oily), emulsions, or suspensions for rectal administration of medicaments for cleansing, diagnostic, or therapeutic purposes.
Ans → enemas
Explanation →
Q. Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Ans → enteric coating
Explanation →
Q. Use of products containing genetic material (e.g., pDNA, antisense DNA, si RNA) to treat a disease or condition, or to modify or manipulate the expression of genetic material or to alter the biological properties of living cells.
Ans → gene therapy
Explanation →
Q. Summary of operations carried out to convert a pharmacologically active compound into a dosage form suitable for administration.
Ans → formulation
Explanation →
Q. Powder particles, which have been aggregated to form larger irregular particles, usually of 0.5–2 mm diameter.
Ans → granules
Explanation →
Q. The Process of contact and adhesion whereby particles in dispersion form larger-size clusters.
Ans → flocculation
Explanation →
Q. Process in which powder particles are made to aggregate to larger particles called granules.
Ans → granulation
Explanation →
Q. An aqueous solution used for the prevention and treatment of mouth and throat infections.
Ans → gargle
Explanation →
Q. Pace at which a drug along with the stomach content leaves and enters the duodenum.
Ans → gastric emptying rate
Explanation →
Q. Time required for the concentration of a reactant in a given reaction to reach a value that is the arith- metic mean of its initial and final (equilibrium) values.
Ans → half life
Explanation →
Q. Crystalline form of a compound in which water molecules are part of the crystal structure.
Ans → hydrate
Explanation →
More one-liners in - Pharmaceutics
Q. A form of experiment in which the participants are, to some degree, kept ignorant of the nature and doses of materials administered as specific parts of the experiment.
Ans → Blind Experiment
Explanation →
Q. A Formulated preparation of molecules/drugs that are rarely if ever suitable for administration to patients without additives.
Ans → dosage form
Explanation →
Q. An overall reaction in which an electrophile binds to a substrate with the expulsion of another electrophile is known as
Ans → electrophilic substitution
Explanation →
Q. The most commonly employed technique for separation of plasma proteins
Ans → Electrophoresis
Explanation →
Q. A a term applied to the selective synthesis of one diastereomeric form of a compound resulting from the influence of an existing chiral centre adjacent to the developing asymmetric carbon atom.
Ans → asymmetric induction
Explanation →
Q. Solid preparation that on contact with water breaks apart by the effect of gas evolution, resulting commonly from the reaction of hydrogen carbonate with citric or tartaric acid, in order to facilitate dissolution or dispersion of the active ingredient before ingestion.
Ans → effervescent tablet
Explanation →
Q. Name the molecule that slides between the stacked nitrogenous bases of the DNA double helix, potentially resulting in a frameshift mutation
Ans → intercalating agent
Explanation →
Q. A a pair of isomers which are related as mirror images of one another.
Ans → enantiomers
Explanation →
Q. Used as processing aid in tablet and capsule manufacturing, to facilitate the movement of the formulation into the dye and punch and to reduce the energy of compression.
Ans → lubricant
Explanation →
Q. Technological process consisting of the application of a substance, which forms a layer e.g, to protect the drug
Ans → coating
Explanation →
Q. A highly infectious zoonotic disease caused by Coxiella burnetii that farmers can contract from their animals by inhalation
Ans → Q fever
Explanation →
Q. Summary of operations carried out to convert a pharmacologically active compound into a dosage form suitable for administration.
Ans → formulation
Explanation →
Q. An antibacterial and antiprotozoan drug of the nitroimidazole class that is activated in anaerobic target cell and introduces DNA strand breakage, thus interfering with DNA replication in target cells
Ans → metronidazole
Explanation →
Q. Scaffold placed into narrowed, diseased vessels (mainly coronary arteries) or a device implanted in a vessel used to help keep it open.
Ans → stent
Explanation →
Q. Process of making dense, spherical pellets by means of special spheronizing or pelletizing equipment.
Ans → spheronization
Explanation →
Q. A virus composed of a nucleic acid core, either DNA or RNA, surrounded by a capsid
Ans → naked virus
Explanation →
Q. Proteins that participate in ribosome assembly during initiation
Ans → initiation factors
Explanation →
Q. The most important enzyme involved in oxidative deamination is
Ans → Glutamate dehydrogenase
Explanation →
Q. An unstable and toxic ions and molecules derived from partial reduction of oxygen
Ans → reactive oxygen species (ROS)
Explanation →
Q. Process of making dense, spherical pellets by means of special spheronizing or pelletizing equipment.
Ans → spheronization
Explanation →
Q. Scaffold placed into narrowed, diseased vessels (mainly coronary arteries) or a device implanted in a vessel used to help keep it open.
Ans → stent
Explanation →
Q. The process by which proteins lose their 3-D (tertiary and secondary) structure by application of an external stress, most often heat.
Ans → Denatured
Explanation →
Q. The very first enzyme elevated in serum in myocardial infarction
Ans → Creatine phosphokinase (CPK)
Explanation →
Q. Inflammation of the conjunctiva in newborns caused by Neisseria gonorrhoeae transmitted during childbirth
Ans → ophthalmia neonatorum
Explanation →
Q. Which are the organic substances relatively insoluble in water, soluble in organic solvents (alcohol, ether).
Ans → Lipids
Explanation →